(Q51029695)

27 March 2018

title

A multimeric immunogen for the induction of immune memory to beta-amyloid. (English)

1 reference

27 March 2018

Piergiuseppe De Berardinis

author

6

1 reference

27 March 2018

author name string

Francesca Mantile

1

1 reference

27 March 2018

Carla Basile

2

1 reference

27 March 2018

Valeria Cicatiello

3

1 reference

27 March 2018

Diana De Falco

4

1 reference

27 March 2018

Antonella Caivano

5

1 reference

27 March 2018

Antonella Prisco

7

1 reference

27 March 2018

publication date

23 November 2010

1 reference

27 March 2018

Immunology & Cell Biology

published in

1 reference

27 March 2018

volume

89

1 reference

27 March 2018

issue

5

1 reference

27 March 2018

page(s)

604-609

1 reference

27 March 2018

Can Alzheimer disease be prevented by amyloid-beta immunotherapy?

cites work

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.134

Active and passive immunotherapy for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.134

Immunology and immunotherapy of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.134

Short amyloid-beta (Abeta) immunogens reduce cerebral Abeta load and learning deficits in an Alzheimer's disease mouse model in the absence of an Abeta-specific cellular immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.134

Alzheimer's disease peptide epitope vaccine reduces insoluble but not soluble/oligomeric Abeta species in amyloid precursor protein transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.134

Immunogenicity and therapeutic efficacy of phage-displayed beta-amyloid epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.134

Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.134

Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.134

Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.134

Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.134

Progress in the active immunotherapeutic approach to Alzheimer's disease: clinical investigations into AN1792-associated meningoencephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.134

Multiple display of peptides and proteins on a macromolecular scaffold derived from a multienzyme complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.134

21 January 2018

Identifiers

DOI

10.1038/ICB.2010.134

1 reference

27 March 2018

1 reference

27 March 2018